Glucolipotoxicity: Fuel Excess and β-Cell Dysfunction
Open accessThe DOI matches its Crossref record; 198 of the 198 references it cites were found in a registry or an index.
Abstract
Glucotoxicity, lipotoxicity, and glucolipotoxicity are secondary phenomena that are proposed to play a role in all forms of type 2 diabetes. The underlying concept is that once the primary pathogenesis of diabetes is established, probably involving both genetic and environmental forces, hyperglycemia and very commonly hyperlipidemia ensue and thereafter exert additional damaging or toxic effects on the beta-cell. In addition to their contribution to the deterioration of beta-cell function after the onset of the disease, elevations of plasma fatty acid levels that often accompany insulin resistance may, as glucose levels begin to rise outside of the normal range, also play a pathogenic role in the early stages of the disease. Because hyperglycemia is a prerequisite for lipotoxicity to occur, the term glucolipotoxicity, rather than lipotoxicity, is more appropriate to describe deleterious effects of lipids on beta-cell function. In vitro and in vivo evidence supporting the concept of glucotoxicity is presented first, as well as a description of the underlying mechanisms with an emphasis on the role of oxidative stress. Second, we discuss the functional manifestations of glucolipotoxicity on insulin secretion, insulin gene expression, and beta-cell death, and the role of glucose in the mechanisms of glucolipotoxicity. Finally, we attempt to define the role of these phenomena in the natural history of beta-cell compensation, decompensation, and failure during the course of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The basis for this loss is multifactorial, and includes glucolipotoxicity32 and amyloid deposition that result in β-cell apoptosis through oxidative as well as endoplasmic reticulum stress31.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
A genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U., et al. (2007) · Science · doi:10.1126/science.1142382 · Cited by 2,753
Reactive oxygen species have a causal role in multiple forms of insulin resistance
Houstis, N., Rosen, E. D., & Lander, E. S. (2006) · Nature · doi:10.1038/nature04634 · Cited by 2,525
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
Clément, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.-M., et al. (1998) · Nature · doi:10.1038/32911 · Cited by 2,346
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232
Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., et al. (2007) · Science · doi:10.1126/science.1142364 · Cited by 2,194
Research works printed but not linked: 1
- Shimabukuro M, Higa M, Zhou YT, Wang MY, Newgard CB, Unger RH 1998 Lipoapoptosis in β-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. J Biol Chem 273:32487–32490 [DOI] [PubMed] [Google Scholar]
Cited by
Items 501–600 of 999
Wu, N., Lu, C., Wang, Y., Liu, L., Lu, D., Zhou, Y. T., He, M., Zhang, X., & Song, G. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.2c05624 · Cited by 29
Striegel, D. A., Hara, M., & Periwal, V. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004423 · Cited by 31
“It is likely that the usual natural history of T2D progression (initial β-cell mass increase [31, 32] followed by β-cell mass loss [36] and functional loss from glucolipotoxicity [58] and inflammation [39]) has resulted in the differences we quantified.”
Backgroundde Oliveira, R. B., Carvalho, C. P. D. F., Polo, C. C., Dorighello, G. G., Boschero, A. C., Oliveira, H. C. F., & Collares‐Buzato, C. B. (2014) · International Journal of Experimental Pathology · doi:10.1111/iep.12084 · Cited by 28
Lv, L.-X., Chen, H., Sun, J., Lu, D., Chen, C., & Liu, D. (2015) · Endocrine · doi:10.1007/s12020-015-0543-8 · Cited by 30
Gray, J. P., & Heart, E. (2010) · Toxicology Mechanisms and Methods · doi:10.3109/15376511003695181 · Cited by 27
Wang, W., Liu, Y., Chen, Y., Cao, C.-P., Xiang, Y., Zhang, D., Han, L., Zhao, H., & Liu, G. (2009) · Peptides · doi:10.1016/j.peptides.2009.11.011 · Cited by 28
Park, S.-M., Choi, J.-S., Nam, T., Ku, J., & Jeong, K. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.03.023 · Cited by 30
Nelson, S. M., Panagiotou, O. A., Anic, G. M., Mondul, A. M., Männistö, S., Weinstein, S. J., & Albanes, D. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw148 · Cited by 28
RACking up ceramide-induced islet β-cell dysfunction
Kowluru, A., & Kowluru, R. A. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.04.026 · Cited by 27
Đorđević, M., Grdović, N., Mihailović, M., Јovanović, J. A., Uskoković, A. S., Rajić, J., Đorđević, M., Tolić, A., Mišić, D. M., Šiler, B., et al. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112043 · Cited by 32
Anti diabetic (AD) activities of L-valinium picrate (LVP) macro and nano crystals
SenthilKannan, K., Ganesh, G., Ali, H. A. J., Krishnaveni, R., & Khan, B. K. (2020) · Materials Today Proceedings · doi:10.1016/j.matpr.2020.01.550 · Cited by 26
Zhang, R., Miao, C., Lin, X., Lin, R., Deng, X., Huang, J., Wang, Y., Xu, Y. S., Weng, S., & Chen, M. (2023) · Carbon · doi:10.1016/j.carbon.2023.118617 · Cited by 26
Chon, S., Rhee, S. Y., Ahn, K. J., Baik, S. H., Park, Y., Nam, M. S., Lee, K. W., Yoo, S. J., Koh, G., Lee, D. H., et al. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13196 · Cited by 30
“critical pathogenesis associated with T2DM and glucotoxicity is known to be the major mechanism underlying this process.(2,3) The rapid normalization of glucose levels in patients with newly diagnosed T2DM through intensive treatment leads to the elimina-”
BackgroundZeitler, P. S. (2019) · World Journal of Pediatrics · doi:10.1007/s12519-019-00247-1 · Cited by 28
Klf6 protects β-cells against insulin resistance-induced dedifferentiation
Dumayne, C., Tarussio, D., Sánchez-Archidona, A. R., Picard, A., Basco, D., Berney, X. P., Ibberson, M. R., & Thorens, B. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.02.001 · Cited by 28
Gu, F., Tao, L., Chen, R., Zhang, J., Wu, X.-Z., Yang, M., Sheng, J., & Tian, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012405 · Cited by 26
Liu, J., Gao, F., Ji, B., Wang, R., Yang, J., Liu, H., & Zhou, F. L. (2014) · Journal of Food Science and Technology · doi:10.1007/s13197-014-1379-6 · Cited by 28
Pan, P., & Dobrowsky, R. T. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-39 · Cited by 27
“T2DM, the concept of “lipotoxicity” [43] or “glucolipotoxicity” [44] has also been proposed for”
Protection of pancreatic β-cell function by dietary polyphenols
Dall’Asta, M., Bayle, M., Neasta, J., Scazzina, F., Bruni, R., Cros, G. H., Rio, D. D., & Oiry, C. (2015) · Phytochemistry Reviews · doi:10.1007/s11101-015-9429-x · Cited by 36
“This scenario leads to a vicious circle that contributes to the decline of the functional b-cell mass and the consequent progression of T2D (Poitout and Robertson 2008).”
BackgroundMeng, Z., Yin, Y., Lv, J., Sha, M., Lin, Y., Gao, L., Zhu, Y., Sun, Y., & Han, X. (2012) · Diabetologia · doi:10.1007/s00125-012-2516-2 · Cited by 26
“inhibit glucose oxidation and impair beta cell function through reactive oxygen species generation and ceramide formation [3].”
BackgroundGallenberger, M., zu Castell, W., Hense, B. A., & Kuttler, C. (2012) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-9-46 · Cited by 30
Dong, F., Zhang, B., Zheng, S., Huang, X., Du, X., Zhu, K., Chen, X., Wu, J., Liu, D., Wen, Z., et al. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00564 · Cited by 30
Portillo-Sánchez, P., Yavuz, S., Bril, F., & Cusi, K. J. (2014) · Current Hepatology Reports · doi:10.1007/s11901-014-0229-3 · Cited by 26
Pascal, S. M. A., Veiga‐da‐Cunha, M., Gilon, P., SCHAFTINGEN, E. V., & Jonas, J. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00503.2009 · Cited by 30
CMPF: A Biomarker for Type 2 Diabetes Mellitus Progression?
Koppe, L., & Poitout, V. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.04.010 · Cited by 25
Self-citationThe Role and Future of FFA1 as a Therapeutic Target
Ghislain, J. J., & Poitout, V. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_51 · Cited by 31
“Etiological studies of T2D progression suggest that chronic hyperglycemia and hyperlipidemia aggravate β-cell dysfunction, a phenomenon known as glucolipotoxicity (Poitout and Robertson 2008; Prentki and Nolan 2006).”
BackgroundSelf-citationSidarala, V., & Kowluru, A. (2017) · APOPTOSIS · doi:10.1007/s10495-017-1354-6 · Cited by 26
“It is well established that exposure to HG results in β-cell dysfunction in diabetes [42, 43].”
Doliba, N. M., Liu, Q., Li, C., Chen, P., Liu, C., Naji, A., & Matschinsky, F. M. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.07.017 · Cited by 26
“Absolute glucose requirement for pancreatic b-cell lipotoxicity both in the culture medium and in the test system used for demonstrating lipotoxicity There is compelling evidence that FAs are toxic in pancreatic b-cells only in the presence of unphysiologically high glucose [38,42,43].”
BackgroundResultMitochondria Associated Membranes (MAMs): Emerging Drug Targets for Diabetes
Sasi, U. S. S., Ganapathy, S., Palayyan, S. R., & Gopalan, R. K. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190212121248 · Cited by 29
Tuo, Y., Wang, D., Li, S., & Chen, C. (2010) · Endocrine · doi:10.1007/s12020-010-9432-3 · Cited by 27
ChREBP regulates Pdx-1 and other glucose-sensitive genes in pancreatic β-cells
Xavier, G. D. S., Sun, G., Qian, Q., Rutter, G. A., & Leclerc, I. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.10.010 · Cited by 31
“Pancreatic b -cell glucolipotoxicity [1] is considered to play a significant role in the pathogenesis of type 2 diabetes.”
BackgroundLee, S., Choi, S., Jung, I., Lee, K. W., & KANG, Y. Y. (2013) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2013.03.011 · Cited by 26
Lee, J., Jung, I., Choi, S., Lee, S.-M., Lee, S., Han, S. J., Kim, H. J., Kim, D. J., Lee, K. W., & KANG, Y. Y. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.12.002 · Cited by 28
Anderson, C., Milne, G. L., Park, Y., Sandler, D. P., & Nichols, H. B. (2018) · Journal of Nutrition · doi:10.1093/jn/nxx022 · Cited by 28
Zhang, J., Bai, J., Zhou, Q., Hu, Y., Wang, Q., Yang, L., Chen, H., An, H. J., Zhou, C., Wang, Y., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04894-7 · Cited by 28
Hung, T., Yang, M., Yu, M.-H., Tsai, I.-N., Tsai, Y.-C., Chan, K., & Wang, C. (2023) · Food & Function · doi:10.1039/d3fo02640j · Cited by 27
Cholesterol Elevation Impairs Glucose-Stimulated Ca2+ Signaling in Mouse Pancreatic β-Cells
Lee, A. K., Yeung-Yam-Wah, V., Tse, F. W., & Tse, A. (2011) · Endocrinology · doi:10.1210/en.2011-0124 · Cited by 27
Exercise and Postprandial Glycemic Control in Type 2 Diabetes
Kearney, M. L., & Thyfault, J. P. (2016) · Current Diabetes Reviews · doi:10.2174/1573399811666150615112441 · Cited by 29
Karbalaei, N., Noorafshan, A., & Hoshmandi, E. (2016) · Experimental Physiology · doi:10.1113/ep085627 · Cited by 25
Lv, X., Nie, C., Shi, Y., Qiao, Q., Gao, J. X., Zou, Y., Yang, J., Chen, L., & Hou, X. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02382-9 · Cited by 28
“For the in vitro experiments, the saturated fatty acid PA, which is widely used in in vitro cell line lipotoxicity studies, induced lipid metabolism disorders in AML12 cells [37].”
The Role of Vegan Diets in Lipotoxicity-Induced Beta-Cell Dysfunction in Type-2-Diabetes
Storz, M. A. (2020) · Journal of Population Therapeutics and Clinical Pharmacology · doi:10.15586/jptcp.v27isp2.744 · Cited by 29
NGBR Is Required to Ameliorate Type 2 Diabetes in Mice by Enhancing Insulin Sensitivity
Chen, Y., Hu, W., Li, Q., Zhao, S., Zhao, D., Zhang, S., Wei, Z., Yang, X., Chen, Y., Li, X., et al. (2020) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100624 · Cited by 25
Protein Kinases in Obesity, and the Kinase-Targeted Therapy
Engin, A. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-63657-8_7 · Cited by 29
Jiang, H., Tong, Y.-X., Yan, D., Jia, S., Östenson, C., & Chen, Z. (2015) · Scientific Reports · doi:10.1038/srep15599 · Cited by 25
Shui, G., Lam, S. M., Stebbins, J. W., Kusunoki, J., Duan, X., Li, B., Cheong, W. F., Soon, D., Kelly, R. P., & Wenk, M. R. (2013) · Metabolomics · doi:10.1007/s11306-013-0494-0 · Cited by 26
Dietary carbohydrate dictates development of Type 2 diabetes in the Nile rat
Bolsinger, J., Prończuk, A., & Hayes, K. C. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.06.004 · Cited by 23
Zeng, L., Lu, H., Deng, H., Mu, P., Li, X., & Wang, M. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0123 · Cited by 27
Zoppi, C. C., Silveira, L. R., de Oliveira, C. A. M., Boschero, A. C., Curi, R., & Carneiro, E. M. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114509993060 · Cited by 25
YOKOYAMA, M., Tanigawa, K., Murata, T., Kobayashi, Y., Tada, E., Suzuki, I., Nakabou, Y., Kuwahata, M., & Kido, Y. (2010) · Nutrition Research · doi:10.1016/j.nutres.2010.03.002 · Cited by 25
“Recent reports indicate that hyperglycemia and elevated FFA negatively impact β-cell functions and glucotoxicity induced by prolonged hyperglycemia which causes β-cell dysfunction and altered β-cell mass [29,30].”
BackgroundWang, Y., Liu, Q., Huan, Y., Li, R., Li, C., Sun, S., Guo, N., Yang, M., Liu, S., & Shen, Z. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.08.011 · Cited by 26
DİLSİZ, S. A., Bacanli, M. G., Anlar, H. G., Çal, T., Arı, N., Bucurgat, Ü. Ü., Başaran, A. A., & Başaran, N. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.11.038 · Cited by 24
Stk24 protects against obesity-associated metabolic disorders by disrupting the NLRP3 inflammasome
Qin, Q., Shou, J., Li, M., Gu, M., Meng, Z., Xu, P., Meng, H., & Wang, X. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109161 · Cited by 25
Paul, R. K., Choudhury, A., Choudhury, S., Mazumder, M. K., & Borah, A. (2015) · Pancreas · doi:10.1097/mpa.0000000000000486 · Cited by 24
“Copyright © 2016 Wolters Kluwer decrease inβ-cell functional status, followed by impaired insulin secretion.(12,13) However, abnormal lipid profile, including elevated levels of triglyceride (TG) as well as small, dense, low-density lipoprotein (LDL) particles and low level of high-density lipoprotein (HDL) cholestero…”
Backgroundβ-Cell Mitochondrial Dysfunction: Underlying Mechanisms and Potential Therapeutic Strategies
Darwish, R., Alcibahy, Y., Abu-Sharia, G., & Butler, A. E. (2025) · Cells · doi:10.3390/cells14231861 · Cited by 26
“Disruption of this complex, either pharmacologically, as with lenalidomide [43], or metabolically, as seen under glucolipotoxic stress [44,45], impairs mitophagy, diminishes mitochondrial respiration, and reduces insulin secretion.”
The required beta cell research for improving treatment of type 2 diabetes
Thorens, B. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12096 · Cited by 26
Lipidomics in gestational diabetes mellitus
Wang, Y., Pan, X., & Pan, A. (2022) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000858 · Cited by 27
Guerra, S. D., D’Aleo, V., Lupi, R., Masini, M., Bugliani, M., Boggi, U., Filipponi, F., & Marchetti, P. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2009.01.004 · Cited by 25
Animal Models of Nutritional Induction of Type 2 Diabetes Mellitus
Barbosa‐da‐Silva, S., Sarmento, I. B., Bargut, T. C. L., Souza‐Mello, V., Águila, M. B., & Mandarim‐de‐Lacerda, C. A. (2014) · International Journal of Morphology · doi:10.4067/s0717-95022014000100046 · Cited by 27
“Thus, the insulin release stimulated by glucose is impaired, and hyperglycemia results (Poitout & Robertson, 2008).”
BackgroundSchvartz, D., Couté, Y., Brunner, Y., Wollheim, C. B., & Sanchez, J. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.018051 · Cited by 27
Han, S. J., Choi, S., Yi, S., Lee, S., Kim, H. J., Kim, D. J., Lee, H. C., Lee, K. W., & KANG, Y. Y. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0340 · Cited by 22
Lam, A. K., Silva, P. N., Altamentova, S. M., & Rocheleau, J. V. (2012) · Integrative Biology · doi:10.1039/c2ib20075a · Cited by 28
Grill, V., Radtke, M., Qvigstad, E., Kollind, M., & Björklund, A. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01119.x · Cited by 24
Incretin-based therapies in type 2 diabetes: A review of clinical results
Bosi, E., Lucotti, P., Setola, E., Monti, L. D., & Piatti, P. M. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.10.003 · Cited by 27
“003 this decline: some are acquired and reversible, such as glucotoxicity and lipotoxicity [8]; some others are still obscure in their pathogenesis, such as amyloid deposition [9] and inflammation [10]; finally, some more are endocrine in nature, including glucagon excess [11] and incretin insufficiency [12].”
BackgroundTao, W., Liu, D., Guo, Z., Han, P., Ma, Y., Wu, M., Zhang, R., & He, J. (2024) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2024.122790 · Cited by 23
Xie, C., Yuan, Y., Wang, Y., Qi, C., Wang, W., An, C., Aikepaer, A., Zhang, Y., Zhang, G., Feng, X., et al. (2025) · Current Obesity Reports · doi:10.1007/s13679-025-00673-5 · Cited by 32
Quantifying β-Cells in Health and Disease: The Past, the Present, and the Need
Kahn, S. E. (2012) · Diabetes Care · doi:10.2337/dc12-1526 · Cited by 22
Loss of Deubiquitinase USP1 Blocks Pancreatic β-Cell Apoptosis by Inhibiting DNA Damage Response
Gorrepati, K. D. D., Lupše, B., Annamalai, K., Yuan, T., Maedler, K., & Ardestani, A. D. (2018) · iScience · doi:10.1016/j.isci.2018.02.003 · Cited by 22
“…(IAPP), alongside with pro-inflammatory cytokines, drive b-cell loss and dysfunction in T2D (Alejandro et al., 2015; Ardestani et al., 2018; Donath et al., 2013; Haataja et al., 2008; Huang et al., 2007; Maedler et al., 2002; Poitout and Robertson, 2008; Robertson et al., 2004; Yuan et al., 2017).”
Backgroundde Hoogh, I. M., Oosterman, J. E., Otten, W., Krijger, A.-M., Berbée, S., Pasman, W. J., van Ommen, B., Pijl, H., & Wopereis, S. (2021) · Nutrients · doi:10.3390/nu13072193 · Cited by 27
Choi, S., Lee, Y.-J., Hwang, G., Chung, J. H., Lee, S., Lee, J.-H., Han, S. J., Kim, H. J., Lee, K. W., Kim, Y., et al. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.10.011 · Cited by 22
Topf, F., Schvartz, D., Gaudet, P., Priego‐Capote, F., Zufferey, A., Turck, N., Binz, P., Fontana, P., Wiederkehr, A., Finamore, F., et al. (2013) · Translational Proteomics · doi:10.1016/j.trprot.2013.03.002 · Cited by 24
Syeda, K., Veluthakal, R., Sidarala, V., & Kowluru, A. (2014) · APOPTOSIS · doi:10.1007/s10495-014-1038-4 · Cited by 25
The Role of PAS Kinase in PASsing the Glucose Signal
Grose, J. H., & Rutter, J. P. (2010) · Sensors · doi:10.3390/s100605668 · Cited by 21
“This and related phenomena, known as glucolipotoxicity, might underlie the pancreatic beta-cell failure observed in Type 2 Diabetes [39].”
BackgroundAssociation Between Oral Isotretinoin Therapy and Unmasked Latent Immuno-Mediated Diabetes
Dicembrini, I., Bardini, G., & Rotella, C. M. (2009) · Diabetes Care · doi:10.2337/dc09-0751 · Cited by 21
“The lipotoxicity, glucotoxicity, and apoptosis of -cells mediated by high levels of circulating fatty acids (3,4) are well known.”
BackgroundNeutzsky-Wulff, A. V., Andreassen, K. V., Hjuler, S. T., Feigh, M., Bay‐Jensen, A., Zheng, Q., Henriksen, K., & Karsdal, M. A. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-214 · Cited by 23
Aguerd, O., Elhrech, H., Fessikh, M. E., Goh, K. W., Omari, N. E., Aanniz, T., & Bouyahya, A. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.106705 · Cited by 24
Dicks, N., Gutierrez, K., Currin, L., de Macedo, M. P., Glanzner, W. G., Mondadori, R. G., Michalak, M., Agellon, L. B., & Bordignon, V. (2021) · Biology of Reproduction · doi:10.1093/biolre/ioab072 · Cited by 22
Acute exposure of beta-cells to troglitazone decreases insulin hypersecretion via activating AMPK
Deng, R., Nie, A., Jian, F., Liu, Y., Tang, H., Zhang, J., Zhang, Y., Shao, L., Li, F., Zhou, L., et al. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.10.021 · Cited by 20
Mohammed, A. M., & Kowluru, A. (2013) · Islets · doi:10.4161/isl.25058 · Cited by 20
Effects of sleep disruption and high fat intake on glucose metabolism in mice
Ho, J. M., Barf, R. P., & Opp, M. R. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.02.024 · Cited by 22
The impact of insulin pump therapy to oxidative stress in patients with diabetic nephropathy
Zhang, X., Zhang, Y., Cheng, Q., Cao, Y., Sun, J., & Lv, X. (2018) · European journal of medical research · doi:10.1186/s40001-018-0304-2 · Cited by 22
“The FFA could also destruct pancreatic β cells to reduce insulin secretion, which lead to hyperglycemia and caused body damage [29, 30].”
BackgroundHou, L., Tang, S., Wu, B. J., Ong, K. L., Westerterp, M., Barter, P. J., Cochran, B. J., Tabet, F., & Rye, K. (2019) · The FASEB Journal · doi:10.1096/fj.201802512rr · Cited by 23
Tremblay, F., Huard, C., Dow, J., Gareski, T., Will, S., Richard, A.-M. T., Syed, J., Bailey, S. A., Brenneman, K. A., Martinez, R. V. P., et al. (2012) · Endocrinology · doi:10.1210/en.2012-1242 · Cited by 24
Iizuka, Y., Kim, H., Izawa, T., Sakurai, K., Hirako, S., Wada, M., & Matsumoto, A. (2016) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2016.10.007 · Cited by 19
“Inflammation and oxidative stress imposed on the pancreas or pancreatic islets are critical factors that contribute to β-cell dysfunction [3, 34].”
BackgroundPractical combination therapy based on pathophysiology of type 2 diabetes
LEVIN, P. A. (2016) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s109216 · Cited by 21
“This in turn interferes with β-cell compensatory mechanisms, collectively contributing to worsened β-cell function and apoptosis.(2,22) The overall extent to which β-cell function is impaired determines the severity of hyperglycemia, and the progressive failure of β-cells accounts for the transition from impaired gluc…”
Ke, B., Zhang, T., An, T., & Lu, R. (2020) · Aging · doi:10.18632/aging.103877 · Cited by 21
“There is mounting evidence that learning and memory abilities are associated with the content of oxidative stress products in the hippocampus [32, 33].”
BackgroundPathophysiology of Prediabetes, Diabetes, and Diabetic Remission in Cats
Gostelow, R., & Hazuchova, K. (2023) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2023.02.001 · Cited by 25
Zhang, X., Damacharla, D., Ma, D., Qi, Y. A., Tagett, R., Drăghici, S., Kowluru, A., & Yi, Z. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.01.008 · Cited by 19
When does diabetes start? Early detection and intervention in type 2 diabetes mellitus
Peralta, F. G., Abreu, C., Cos, X., & Gómez‐Huelgas, R. (2020) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2019.12.004 · Cited by 26
White, S. A., Zhang, L. S., Pasula, D. J., Yang, Y. H. C., & Luciani, D. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-67755-3 · Cited by 26
Bosi, E., Marselli, L., Luca, C. D., Suleiman, M., Tesi, M., Ibberson, M. R., Eizirik, D. L., Cnop, M., & Marchetti, P. (2020) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqaa097 · Cited by 19
Truchan, N. A., Fenske, R. J., Sandhu, H. K., Weeks, A. M., Patibandla, C., Wancewicz, B., Pabich, S., Reuter, A., Harrington, J. M., Brill, A. L., et al. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00045 · Cited by 19
Long-term culture and functionality of pancreatic islets monitored using microelectrode arrays
Schönecker, S., Kraushaar, U., Düfer, M., Sahr, A., Härdtner, C., Guenther, E., Walther, R., Lendeckel, U., Barthlen, W., Krippeit‐Drews, P., et al. (2014) · Integrative Biology · doi:10.1039/c3ib40261d · Cited by 24
Red Wine and Diabetes Health: Getting Skin in the Game
Robertson, R. P. (2013) · Diabetes · doi:10.2337/db13-1318 · Cited by 20
“The glucose toxicity hypothesis holds that continual exposure to high postprandial glucose levels over time steadily generates excess ROS that constantly nibble away at cells and their normal function (38).”
BackgroundSelf-citationBarre, D. E., Mizier-Barre, K. A., Griscti, O., & Hafez, K. (2016) · Endocrine Regulations · doi:10.1515/enr-2016-0020 · Cited by 21
“…1988; Eriksson et al. 1991; Butler et al. 2001; Blaak 2003; Hawkins et al. 2003; Moore et al. 2004; Robertson et al. 2004; Poitout et al. 2006; Delarue and Magnan 2007; Ye 2007; Poitout and Robertson 2008; Poitout et al. 2010; Boden 2011; Karpe et al. 2011; Morita et al. 2012; Salgin et al. 2012).”
BackgroundThe roles of telomeres and telomerase in β‐cell regeneration
Liew, C. W., Holman, A., & Kulkarni, R. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01103.x · Cited by 23
Intrapancreatic adipocytes and beta cell dedifferentiation in human type 2 diabetes
Zhang, N., Sun, Q., Zhang, J., Zhang, R., Liu, S., Zhao, X., Ma, J., & Li, X. (2025) · Diabetologia · doi:10.1007/s00125-025-06392-9 · Cited by 25
Deepak, K., Shee, M., Roy, P., & Mandal, M. (2026) · Cell Death · doi:10.1016/j.celld.2026.100009 · Cited by 25
Metabolism and chromatin dynamics in health and disease
Rodriguez, H., Rafehi, H., Bhave, M. R., & El‐Osta, A. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.09.004 · Cited by 19
Gezginci-Oktayoğlu, S., Sancar, S., Kaçar, A. K., & Bolkent, Ş. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30129 · Cited by 16
“As hyperglyce- mia is considered a prerequisite for the occurrence of lipotoxicity, it has been suggested that instead of lipotoxicity, the condition of glucolipotoxicity would be more appropriate to identify the dele- terious effects of lipids (Harmon et al., 2001; Poitout & Robertson, 2008).”
BackgroundGap junction coupling and islet delta-cell function in health and disease
MIRANDA, C. A., Samad, M., Vergari, E., & Briant, L. J. B. (2021) · Peptides · doi:10.1016/j.peptides.2021.170704 · Cited by 23
Metadata
- Authors
- Poitout, V., & Robertson, R. P.
- Affiliations
- Pacific Northwest Research Institute (US)
- University of Washington (US)
- Corresponding author
- Poitout, Vincent
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2008-05
- Volume
- 29
- Issue
- 3
- Pages
- 351-366
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC2528858
- OpenAlex
- W2082515526
- Cited by
- 1,092
- References
- 198
- Citations by year
- 2026: 47 · 2025: 55 · 2024: 37 · 2023: 42 · 2022: 38 · 2021: 57 · 2020: 61 · 2019: 50 · 2018: 44 · 2017: 61 · 2016: 79 · 2015: 64 · 2014: 59 · 2013: 81 · 2012: 84
- FWCI
- 81.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (77686)
- National Institute of Diabetes and Digestive and Kidney Diseases (R-01-DK-38325, R01 DK 58096, R01DK038325, R01DK058096)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- glucolipotoxicity, glucotoxicity, lipotoxicity, type 2 diabetes, beta-cell dysfunction, hyperglycemia, hyperlipidemia, oxidative stress, insulin secretion, insulin gene expression, beta-cell death, insulin resistance, beta-cell compensation, beta-cell failure
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Energy Metabolism, Glucose, Humans, Lipid Metabolism, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.